NCT03971383View on ClinicalTrials.gov

Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

October 31, 2020

Study Completion Date

May 3, 2021

Conditions
Functional Dyspepsia
Interventions
DRUG

Aolanti Weipang Tablets

3 tablets one time, 3 times a day(tid)

DRUG

Placebo

3 tablets one time, 3 times a day(tid)

Trial Locations (1)

Unknown

The Second People's Hospital of Fujian Province, Fuzhou

Sponsors
All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY